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doi:10.1Objectives: Closed and miniaturized cardiopulmonary bypass circuits, which eliminate cardiotomy suction and
open venous reservoirs with a reduced priming volume, have been reported to be advantageous. We compara-
tively examined the respective contribution of cardiotomy suction and open venous reservoirs to perioperative
activation in coagulofibrinolysis and inflammation systems, with identical conditions of priming volume and
anticoagulation.
Methods: A total of 75 consecutive coronary artery bypass grafting procedures were performed using 1 of the
following 3 cardiopulmonary bypass circuits under identical conditions of priming volumes, heparin coating,
and protocols of anticoagulation and transfusion, as follows: a circuit with an open venous reservoir and cardi-
otomy suction (open group, n ¼ 25), a circuit with an open venous reservoir without cardiotomy suction
(nonsuction group, n ¼ 25), or a circuit without either (closed group, n ¼ 25). Blood samples were collected
at 8 points up to the first postoperative morning.
Results: The thrombin-antithrombin III complex, fibrinogen degeneration products, D-dimer, plasmin-a2 plas-
min inhibitor complex, and plasminogen activator inhibitor-1 levels were significantly greater in the open group
than those in the other 2 groups (P<.0001, for all markers). The C3a and interleukin-6 levels were similar among
all the groups. The incidences of perioperative transfusion and postoperative bleeding were increased and the
early graft patency rate of saphenous veins was lower in the open group than those in the other 2 groups.
Conclusions: Cardiotomy suction, but not open venous reservoirs, causes perioperative coagulofibrinolysis
activation, although neither affects the inflammation system. The use of cardiotomy suction needs to be examined
further in association with postoperative PAI-1 elevation and early vein graft occlusion. (J Thorac Cardiovasc
Surg 2011;141:1289-97)Closed and miniaturized cardiopulmonary bypass (CPB) cir-
cuits, which have recently been applied, particularly in coro-
nary artery bypass grafting (CABG), appear to be
a fundamental and important innovation in CPB technol-
ogy.1-7 These circuits are not equipped with cardiotomy
suction or open venous reservoirs and, consequently, enable
extreme miniaturization of the circuit. In clinical studies,
these circuits have been shown to improve the clinical
outcomes and suppress various perioperative plasma
markers compared with conventional open circuits1,2 and,
furthermore, have been comparable to those found during
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Mof closed and miniaturized circuits is supposedly derived
from the following 3 components: the elimination of
cardiotomy suction, the elimination of open venous
reservoirs, and the extreme miniaturization of the circuit.
The activation of coagulofibrinolysis and inflammation
systems are important issues in cardiac surgeries using
CPB and lead to various adverse outcomes, particularly in
high-risk patients.8,9 Thrombin is a key enzyme in these
systems,9 and anticoagulation with heparin is essential
during CPB.10 Even with standard heparinization and
heparin-coated circuits, thrombin generation is inevitable
in cardiac surgeries using CPB.9-11 Cardiotomy suction
and open venous reservoirs have been demonstrated to
contribute to the activation of the coagulofibrinolysis and
inflammation systems12-16; however, the contribution of
each has not yet been comparatively examined.7 In the use
of closed and miniaturized circuits, highly sophisticated
miniaturization can also affect the coagulofibrinolysis and
inflammation systems owing to the prevention of hemodilu-
tion and a reduction of the blood–circuit contact area.17
In the present prospective clinical study, we compared the
respective effect of cardiotomy suction and open venous
reservoirs on the coagulofibrinolysis and inflammation
systems, setting identical conditions of priming volumes,diovascular Surgery c Volume 141, Number 5 1289
Abbreviations and Acronyms
ACT ¼ activated clotting time
APTT ¼ activated partial thromboplastin time
AT ¼ antithrombin III
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
FDPs ¼ fibrinogen degeneration products
IL ¼ interleukin
OPCAB ¼ off-pump CABG
PAI-1 ¼ plasminogen activator inhibitor-1
PIC ¼ plasmin-a2 plasmin inhibitor complex
PRBCs ¼ packed red blood cells
PT ¼ prothrombin time
TAT ¼ thrombin-antithrombin III complex
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Mheparin coating, and protocols of anticoagulation and
transfusion.MATERIALS AND METHODS
Study Population
Between October 2006 and June 2009, 75 elective, primary, isolated
CABGs at Osaka City University Hospital (Osaka, Japan) were prospec-
tively randomized for use of 1 of the following CPB circuits: a circuit
with an open venous reservoir and cardiotomy suction (open group,
n¼ 25), a circuit with an open venous reservoir without cardiotomy suction
(nonsuction group, n ¼ 25), or a circuit without either (closed group,
n ¼ 25). The exclusion criteria included single-vessel disease, preoperative
administration of heparin, coagulofibrinolysis disorders, renal or liver dys-
function, and inflammatory or malignant disease. Anticoagulants and anti-
platelet agents were discontinued at least 7 days before surgery. The
institutional review board at our institution approved the study, and all
patients provided informed consent for the study.
Study Protocols
Anesthetic protocol and operative procedure. A standard-
ized anesthetic protocol was used. No premedication was administered. An-
esthesia was induced with intravenous midazolam and fentanyl and
maintained with fentanyl, propofol, vecuronium bromide, and inhalation
of sevoflurane. No patient received perioperative corticosteroids, aprotinin,
or tranexamic acid.
Amedian sternotomy approach was used for all patients. The left internal
thoracic artery and other graft materials were harvested simultaneously. Af-
ter systemic heparinization, CPB was established with an arterial cannula to
the ascending aorta and a 2-stage cannula through the right atrial appendage.
To avoid air entrainment and leaky bleeding through the purse-string suture
around the venous cannula, an extra tie was added around the insertion site
of the atrial appendage. A left ventricular vent was inserted through the right
upper pulmonary vein. During CPB, a nonpulsatile flow of 2.4 L/min/m2
body surface area was maintained under moderate systemic hypothermia
(rectal temperature, 32C), and the mean arterial pressure was controlled
within the range of 50 to 80 mm Hg.
After aortic crossclamping, identical cold blood cardioplegia was admin-
istered through the aortic root, followed by intermittent administration in the
antegrade and retrograde directions. All proximal, as well as distal, coronary
anastomoses were constructed using hand suturing during 1 aortic clamp-
ing. After termination of CPB and achievement of hemostasis, all patients1290 The Journal of Thoracic and Cardiovascular Surwere postoperatively admitted to the intensive care unit. The blood from
the postoperative chest drains was discarded.
CPB circuits and suction strategy. The circuits in all groups
consisted of a hollow-fiber membrane oxygenator (Affinity NTOxygenator,
CB511), a centrifugal blood pump (Bio-Pump, CBBPX80), and an arterial
filter (Affinity Arterial Filter, CB351; all 3 components from Medtronic
Cardiac Surgery, Minneapolis, Minn). All the components of the circuits
in all groups were coated with covalently-bonded heparin (Carmeda BioAc-
tive Surface, Carmeda AB, Upplands Vasby, Sweden). The circuits in all the
groups were primed with identical fluid (1300 mL), a mixture of 1000 mL
lactated Ringer’s solution, 200 mL mannitol (200 mg/mL), and 100 mL so-
dium bicarbonate (84 mg/mL). The differences in the circuits and suction
strategy among the groups are described below and shown in Figure 1.
Open group. For the open group, the circuit contained a hard-shell ve-
nous reservoir (Affinity CVR Reservoir, 61399409462, Medtronic Cardiac
Surgery). During systemic heparinization, pericardial bloodwas collected in
the reservoir through cardiotomy suction. At all other times, the pericardial
suction blood was processed by an autotransfusion cell-saving device
(Electa with a bowel of BT225, Dideco, Sorin Group, Mirandola, Italy)
and transfused.
Nonsuction group. For the nonsuction group, the circuit contained
a hard-shell venous reservoir just as in the open group. Cardiotomy suction
was not used, and a cell-saving device was applied throughout the operation.
Closed group. For the closed group, the circuit was designed using the
basic structure of the Medtronic Resting Heart System (Medtronic Cardiac
Surgery). The circuit eliminated an open venous reservoir and was equipped
with a collapsible soft reservoir in the side of venous return for temporary
blood retention. Cardiotomy suction was not used, and a cell-saving device
was applied throughout the operation.
Anticoagulation and blood product use. The protocols for
anticoagulation and blood product use were similar for all groups. Before
aortic cannulation, all patients received 300 IU/kg bovine heparin. The
celite-activated activated clotting time (ACT; Hemochron 801, International
Technidyne Corp, Edison, NJ) was used to guide heparin anticoagulation,
and the ACT was maintained at 400 seconds or more by the additional
administration of heparin, as required. After the termination of CPB, the
heparin was neutralized with 4.5 mg/kg of protamine.
Packed red blood cells (PRBCs) were transfused to maintain the hemat-
ocrit at 23% or more during CPB and 28% or more after the termination of
CPB.
Data collection and measurements. Blood samples were
obtained from a radial arterial catheter or the arterial side of the CPB circu-
lation at the following 8 observation times: T1, before the induction of an-
esthesia; T2, 1 hour after the initiation of CPB; T3, 10 minutes after aortic
declamping; T4, 5 minutes after protamine administration; T5, T6, and T7,
1, 3, and 6 hours after the termination of CPB, respectively; and T8, the first
postoperative morning. The hematocrit and platelet count were immediately
measured using an automated cell counter (MAXM-Retic, Beckman Coul-
ter, Inc, Fullerton, CA). The other citrated samples were centrifuged at
3000g for 10 minutes, and the plasma was stored at80C for later analysis.
The coagulation, fibrinolysis, and inflammation markers were measured
using reagents according to the manufacturer’s instructions, as follows. The
activated partial thromboplastin time (APTT) wasmeasured using the Lang-
dell method and Hemosil SynthASil (Instrumentation Laboratory, Bedford,
MA). The prothrombin time (PT) was determined using the 1-stage method
of Quick using Thromborel S (Sysmex Corp, Hyogo, Japan). Antithrombin
III (AT) was determined using the absorbance photometry method for chro-
mogenic substrates using Testzyme S ATIII (Sekisui Medical Corp, Tokyo,
Japan). The plasma thrombin-antithrombin III complex (TAT) levels, which
reflect the amount of thrombin generated in the circulating blood, were mea-
sured using an enzyme-linked immunoassay method and TAT [S] (TFB Inc,
Tokyo, Japan). The plasma levels of fibrinogen degeneration products
(FDPs) were determined using an absorbance photometry method for latex
turbidimetry tests and Nanopia P-FDP (Sekisui Medical Corp, Tokyo,gery c May 2011
FIGURE 1. Schema showing components of cardiopulmonary bypass circuits in each group. Circuit in open group consisted of open venous reservoir (OVR)
and cardiotomy suction (CS); circuit in nonsuction group consisted of OVR without CS; and circuit in closed group consisted of neither OVR nor CS.
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plex (PIC), and plasminogen activator inhibitor-1 (PAI-1) were measured
using a latex photometric immunoassay and LPIA-ACE D-dimer, LPIA
PPIII, and LPIA tPAI test, respectively (Mitsubishi Chemical Medience
Corp, Tokyo, Japan). C3a was measured by radioimmunoassay using the
human complement C3a des Arg EIA Kit (Assay Designs Inc, Ann Arbor,
MI). The serum levels of interleukin (IL)-6 were measured with the chemi-
luminescent enzyme immunoassay technique using human IL-6 CLEIA
(Fujirebio Inc, Tokyo, Japan).
Coronary angiography. Coronary angiography was performed
within 3 weeks after surgery in all patients.
Statistical analysis. All statistical analyses were performed using the
Statview, version 5.0, software package (SAS Institute, Cary, NC). Data are
presented as the mean standard deviation in the text and tables and as the
mean  standard error in the graphs. The clinical profiles of the 3 groupsTABLE 1. Preoperative characteristics
Variable Open group (n ¼ 25) Nons
Age, y 66.2  9.3
Male/female, n 16/9
BMI, kg/m2 22.9  2.7
BSA, m2 1.63  0.2
LVEF,% 46.9  14.6
CCS score 1.84  0.69
Diseased vessels, n (%) 2.8  0.4
Two vessels 5 (20)
Three vessels 20 (80)
Smoking, n (%) 12 (48)
Creatinine, mg/dL 0.95  0.30
Diabetes mellitus, n (%) 10 (40)
Insulin 5 (20)
Oral agents 5 (20)
Hypertension, n (%) 19 (76)
Hyperlipidemia, n (%) 13 (52)
Preoperative medications, n (%)
ACE inhibitors 1 (4)
ARBs 7 (28)
b-Blockers 12 (48)
Calcium channel blockers 11 (44)
Statins 12 (48)
Nitrate agents 10 (40)
Values are expressed as mean SD, or as indicated.BMI, Body mass index; BSA, body surfa
functional class; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor block
The Journal of Thoracic and Carwere compared using c2 tests or Fisher’s exact probability tests for qualita-
tive variables and unpaired t tests or the Mann-Whitney U test for quantita-
tive variables. Within the groups, post hoc multiple comparisons were made
using Tukey’s test. A repeated measures analysis of variance was performed
to compare the laboratory parameters among the 3 groups. If significant
differences were found, Bonferroni’s corrected comparisons with Student’s
t tests were made at individual observation times within the groups.RESULTS
Perioperative Clinical Data
The preoperative patient data are summarized in Table 1.
No significant differences were detected in the clinical
variables among the 3 groups. Complete revascularizationuction group (n ¼ 25) Closed group (n ¼ 25) P value
68.2  8.6 66.1  8.7 .68
18/7 19/6 .64
24.3  3.1 24.4  3.3 .17
1.67  0.15 1.67  0.2 .59
52.2  12.9 50.6  10.6 .37
1.95  0.51 1.72  0.61 .52
2.6  0.5 2.8  0.4 .43
8 (32) 5 (20) .52
17 (68) 20 (80) .52
10 (40) 12 (48) .81
1.04  0.44 0.99  0.32 .70
11 (44) 13 (52) .69
6 (24) 5 (20) .92
5 (20) 8 (32) .92
20 (80) 23 (92) .30
13 (52) 15 (60) .81
2 (8) 4 (16) .33
11 (44) 13 (52) .21
13 (52) 13 (52) .95
9 (36) 8 (32) .67
10 (40) 13 (52) .89
11 (44) 11 (44) .95
ce area; LVEF, left ventricular ejection fraction;CCS, Canadian Cardiovascular Society
er.
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TABLE 2. Intraoperative data
Variable Open group (n ¼ 25) Nonsuction group (n ¼ 25) Closed group (n ¼ 25) P value
Duration of procedure, min
Operation 319  55 301  40 307  40 .39
Cardiopulmonary bypass 157  34 143  30 152  29 .38
Aortic crossclamp 124  30 114  28 120  26 .55
Total cardioplegia, mL 1944  621 1693  231 1994  634 .25
Collection with cell saving device during CPB NA 1563  487 1440  438 .34
Total heparin dose, 3103 IU/kg 19.7  4.4 22.1  4.2 20.5  5.7 .25
Need for additional heparin, n (%) 9 (36) 10 (40) 7 (28) .66
Mean ACT during CPB 557  96 554  129 548  89 .92
Total protamine dose, U/kg 27.0  4.4 28.4  4.6 28.1  5.4 .44
Number of distal anastomoses, n 3.7  0.9 3.6  1.0 3.8  0.9 .73
Number of grafts 2.8  0.5 2.7  0.5 2.8  0.4 .56
Details of grafts, n (%)
Left ITA 25 (100) 25 (100) 24 (96) .36
Radial artery 13 (52) 13 (52) 14 (56) .95
Saphenous veins 24 (96) 23 (92) 24 (96) .77
Values are expressed as mean  SD, or as indicated. CPB, Cardiopulmonary bypass; ACT, activated clotting time; ITA, internal thoracic artery; NA, not applicable.
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Mwas achieved in all patients, and no patients were excluded
from the study. Also, no significant differences were
noted among the 3 groups in the intraoperative variables
(Table 2).
Hematocrit and Platelet Count
No significant differences were found in the perioperative
changes in the hematocrit or platelet counts among the 3
groups (Figure 2).
Coagulation and Fibrinolytic Systems
No significant differences were seen in the perioperative
changes in the APTT, PT, or AT (Figure 3, A) among the 3
groups. The mean of ACTs at the induction of CPB and 1
hour later showed no significant differences among the 3
groups (Table 2). The perioperative levels of TAT, FDPs,
D-dimer, PIC, and PAI-1 differed significantly among the 3
groups (P< .0001 for each variable; Figures 3, B–F). All
these variables were identical among the nonsuction andFIGURE 2. Perioperative changes in hematocrit and platelet count. No significa
lines indicate limit of normal range.Gray columns indicate period of cardiopulmo
group; closed circles, closed group; T1, before induction of anesthesia; T2, 1 hour
after protamine administration; T5, T6, and T7, 1, 3, and 6 hours after the of CP
1292 The Journal of Thoracic and Cardiovascular Surclosed groups. In the open group, the TAT, FDP, andD-dimer
levels increased during CPB and peaked at T4 and then con-
tinued to be significantly greater than those in the other 2
groups from T2 through T7. In the nonsuction and closed
groups, the TAT levels did not increase during CPB (T2
and T3) but were significantly increased after protamine ad-
ministration (T3 vs T4, P ¼ .001). The PIC levels in the
open group were increased at T3 and continued to be
significantly greater than those in the other 2 groups from
T3 through T7. The PAI-1 levels did not increase until T4
in all groups; however, the PAI-1 levels in the open group
tended to be greater than those in the other 2 groups. On the
first postoperative morning, the TAT, FDP, D-dimer, PIC,
and PAI-1 levels were comparable among the 3 groups.
Inflammation Systems
No significant differences were found in the perioperative
changes in the C3a or IL-6 levels among the 3 groups
(Figure 4).nt differences found in hematocrit or platelet counts among 3 groups.Dotted
nary bypass (CPB); open circles, open group; semiclosed circles, nonsuction
after initiation of CPB; T3, 10minutes after aortic declamping; T4, 5minutes
B, respectively; T8, first postoperative morning.
gery c May 2011
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FIGURE 3. Perioperative change in coagulofibrinolysis markers. A, antithrombin III (AT); B, thrombin-antithrombin III complex (TAT); C, fibrinogen deg-
radation products (FDPs); D, D-dimer; E, plasmin-a2 plasmin inhibitor complex (PIC); and F, plasminogen activator inhibitor-1 (PAI-1) levels. No signif-
icant differences found in AT among 3 groups. *P<.01 and **P<.001 between open and nonsuction or closed group. Dotted lines indicate limit of normal
range.Gray columns indicate period of cardiopulmonary bypass (CPB); open circles, open group; semiclosed circles, nonsuction group; closed circles, closed
group; T1, before induction of anesthesia; T2, 1 hour after initiation of CPB; T3, 10 minutes after aortic declamping; T4, 5 minutes after protamine admin-
istration; T5, T6, and T7, 1, 3, and 6 hours after the of CPB, respectively; T8, first postoperative morning.
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Postoperative blood loss during the first 6, 12, and 24 hours
tended to be greater in the open group than in the other 2
groups, although this difference was not significant (Table 3).FIGURE 4. Perioperative changes in C3a and interleukin (IL)-6 levels. No signi
Gray columns indicate period of cardiopulmonary bypass (CPB); open circles, op
T1, before induction of anesthesia; T2, 1 hour after initiation of CPB; T3, 10minu
T6, and T7, 1, 3, and 6 hours after the of CPB, respectively; T8, first postoperat
The Journal of Thoracic and CarThe transfusion of PRBCs during CPB was comparable
among the 3 groups; however, transfusions of PRBCs after
the weaning of CPB tended to be greater in the open group
than in the other 2 groups (open vs nonsuction or closedficant differences among groups.Dotted lines indicate limit of normal range.
en group; semiclosed circles, nonsuction group; closed circles, closed group;
tes after aortic declamping; T4, 5minutes after protamine administration; T5,
ive morning.
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TABLE 3. Perioperative data and outcomes
Variable Open group (n ¼ 25) Nonsuction group (n ¼ 25) Closed group (n ¼ 25) P value
Lactate on ICU admission, mmol/L 2.0  0.9 2.0  0.8 1.9  0.8 .78
Postoperative maximum C-reactive
protein, mg/dL
17.0  3.3 19.3  5.6 19.0  4.7 .24
Postoperative blood loss, mL
Within 6 h 274  139 215  72 229  94 .16
Within 12 h 382  177 327  118 335  102 .35
Within 24 h 572  239 457  147 448  118 .55
Transfusion of blood products
Total PRBC, U 10.7  4.9 8.6  5.7 8.9  5.5 .35
During CPB 3.4  2.7 3.3  2.4 3.3  2.8 .22
After CPB 7.2  3.2 5.3  5.1 5.6  3.6 .19
Total FFP, U 14.6  6.2 10.6  4.8 10.6  4.7 .15
Need for platelets, n (%) 4 (16) 2 (8) 1 (4) .33
Postoperative complications, n (%)
Re-exploration for bleeding 0 (0) 0 (0) 0 (0) NA
New atrial fibrillation 7 (28) 6 (24) 8 (32) .82
Stroke 1 (4) 1 (4) 0 (0) .60
Deep sternal infection 2 (8) 0 (0) 0 (0) .13
Renal failure (creatine>2.0 mg/dL) 1 (4) 2 (8) 2 (8) .80
IABP support 0 (0) 0 (0) 0 (0) NA
Early graft patency,% 93.5 97.1 98.9 .11
Left ITA 100 100 100 NA
Radial artery 92.3 92.3 100 .48
Saphenous veins 83.9 96.8 96.8 .13
Values are expressed as mean  SD, or as indicated. ICU, Intensive care unit; PRBC, packed red blood cells; CPB, cardiopulmonary bypass; FFP, fresh frozen plasma; Cre, cre-
atinine; IABP, intra-aortic balloon pump; ITA, internal thoracic artery; NA, not applicable.
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ative total transfusions of PRBCs or fresh frozen plasma oc-
curred in the open group than in the nonsuction and closed
groups, although the differences were not significant
(Table 3).
Early Graft Patency
The overall graft patency rate was 95.4%. The patency
rates of the internal thoracic artery and radial artery were
similar among the 3 groups (Table 3). The saphenous vein
graft patency rate in the open group was lower than that in
the nonsuction and closed groups, although the differences
were not significant (open vs nonsuction or closed group,
P ¼ .17 and P ¼ .091, respectively).
DISCUSSION
The results from the present prospective, randomized
study have provided a clear comparison between cardiotomy
suction and open venous reservoirs in the coagulofibrinoly-
sis and inflammation systems, excluding the bias of hemodi-
lution and anticoagulation. We found that the use of
cardiotomy suction was the leading cause of coagulofibri-
nolysis activation and that the use of open venous reservoirs,
which have 2 nonphysiologic aspects of blood–air interface
and blood retainment, did not affect the coagulofibrinolysis
system.1294 The Journal of Thoracic and Cardiovascular SurThe present results show that thrombin was generated
during CPB with the use of cardiotomy suction. Although
the use of cardiotomy suction has been considered to influ-
ence the coagulation pathway owing to both the suction
force and the blood contact with wound tissue factor, Fabre
and colleagues18 reported that the suction force is not asso-
ciated with thrombin formation. The present results that the
open group alone showed a significant TAT elevation is
consistent with previous clinical and hematologic observa-
tions that blood interference with wound tissue factor with
the use of cardiotomy suction results in thrombin generation
through the extrinsic coagulation pathway in cardiac
surgery.14,19,20
The lack of thrombin generation in the nonsuction and
closed groups, in which cardiotomy suction was eliminated
and the extrinsic coagulation pathway was not activated,
provides important data about the mechanism of action of
heparin and the extent of heparinization necessary for
CPB. Heparin acts as an anticoagulant by amplifying ATIII,
which blocks the coagulation factors XIIa, XIa, IXa, Xa, and
thrombin (IIa) in the intrinsic coagulation pathway.10 Al-
though the contact of blood with a negatively charged circuit
surface activates the intrinsic coagulation pathway, in our
study, thrombin activity was almost completely suppressed
by heparinization in the nonsuction and closed groups.
These observations indicate that heparin successfully blocksgery c May 2011
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the intrinsic coagulation pathway before reaching the stage
of thrombin activation. The lack of participation of the in-
trinsic coagulation pathway in thrombin activation during
CPB can also explain a previous finding that patients lacking
factor XII, a trigger enzyme in the intrinsic coagulation path-
way, have an extent of perioperative thrombin activation
equivalent to that of normal cardiac surgery patients under-
going CPB.21 Furthermore, if heparin-coated circuits were
used without cardiotomy suction, the magnitude of heparin-
ization can be reduced up to the level at which thrombin
activation starts to be observed, without applying empiric
anticoagulation protocols.10,11 Despite the increase in the
hemostatic markers (TAT, FDPs, D-dimer, PIC) observed
only in the open group, the total heparin dose, mean ACT
during CPB, and perioperative change of AT showed no
differences among the 3 groups. These findings lead to the
questions of whether the elevated hemostatic markers
resulting from the use of cardiotomy suction really
indicate the activation of systemic coagulability; and
whether ACT is appropriate for an anticoagulation
assessment during CPB.
The time lag in the elevation of TAT, PIC, and PAI-1
levels in the open group was consistent with time course
of the hemostatic mechanism. When vascular injury occurs
and blood interferes with tissue factor, hemostatic action oc-
curs in the following order: fibrin network formation occurs
through the coagulation pathway, fibrin is removed by fibri-
nolysis, and fibrinolysis is then suppressed.10,22 The TAT,
PIC, and PAI-1 levels determine the extent of activity for
coagulation, fibrinolysis, and fibrinolysis inhibition, respec-
tively, and the time course of these markers in the open
group in our study was consistent with a hemostatic mecha-
nism. Fibrinolysis is activated by the retransfusion of peri-
cardial wound blood, which is rich in tissue plasminogen
activator.23 We found that the peak D-dimer levels were dif-
ferent from the PIC levels in the open group, although both
are fibrinolytic markers. This discrepancy could have re-
sulted from differences in how these markers specifically
characterize fibrinolysis. PIC represents the amount of plas-
min formation, indicating fibrinolytic activity. In contrast,
D-dimer represents the amount of degeneration products
from fibrin by fibrinolysis, and the amount of D-dimer de-
pends on the amount of fibrin in the systemic circulation
in addition to fibrinolytic activity. Thus, the peak of D-dimer
levels at the end of CPB in the open group indicated that
cardiotomy suction provides sufficient fibrin to the systemic
circulation.
PAI-1 has recently been reported as a remarkablemarker to
predict early vein graft occlusion after CABG.24-26 The
previous findings of the relation between PAI-1 elevation
and vein graft occlusion could explain the present results in
which the open group, with the greatest values of PAI-1,
showed the lowest graft patency rate of the saphenous veinThe Journal of Thoracic and Cargrafts.24-26 Any method to suppress the postoperative PAI-1
elevation might be helpful for obtaining better vein graft
patency. The relationships between the use of cardiotomy
suction, postoperative PAI-1 elevation, and early vein graft
occlusion remain to be examined in a larger study population.
The similar results of C3a and IL-6 levels among the 3
groups showed that neither cardiotomy suction nor an
open venous reservoir influences the inflammation system.
Because even the closed group without cardiotomy suction
or open venous reservoirs resulted in elevation of the inflam-
matory markers suggests that extracorporeal circulation
through a heart-lung machine is the leading cause of perio-
perative inflammatory activation. The comparative results
of the postoperative maximum C-reactive protein levels
also suggested that the extent of postoperative inflammatory
activation was not different among the 3 groups. The aver-
age peak IL-6 value in all patients in the present study was
225 pg/mL 6 hours after surgery. Mazzei and colleagues4 re-
ported that the peak IL-6 value in CABG patients using
a minimal extracorporeal circulation system and in OPCAB
patients was 167 and 181 pg/mL 6 hours after surgery, re-
spectively. The miniaturization of circuits and the elimina-
tion of CPB might suppress perioperative inflammatory
activation, although a randomized study is necessary to
confirm this speculation.
The identical changes in platelet counts among the 3
groups in our study have clearly shown that neither cardiot-
omy suction nor an open venous reservoir is associated with
perioperative thrombocytopenia. In our study, we set an
identical priming volume of 1300 mL in all groups to avoid
the effect of hemodilution, resulting in identical platelet
counts. In contrast, Sakwa and colleagues1 compared closed
and miniaturized circuits (a priming volume of 900 mL)
with conventional open circuits (a priming volume of
1850 mL) and concluded that closed and miniaturized cir-
cuits significantly preserved platelet count. Thus, it is possi-
ble that the difference in the findings between the 2 studies
resulted from the difference in the priming volume. This
possibility suggests that hemodilution by the priming
volume in a CPB circuit largely influences perioperative
thrombocytopenia.
For perioperative blood conservation, the alternative use
of cell-saving devices, which has been suggested in an
evidence-based review,27 instead of cardiotomy suction,
might be justified by the several negative results associated
with the use of cardiotomy suction found in our study. The
open group, which used cardiotomy suction, was associated
with more activation in coagulofibrinolysis and worse re-
sults, with an increase in postoperative blood loss and peri-
operative transfusions, compared with the other 2 groups.
However, Rubens and colleagues15 reported negative results
with the alternative use of cell-saving devices for periopera-
tive blood conservation. This discrepancy in the findings be-
tween the 2 studies could have been because the study bydiovascular Surgery c Volume 141, Number 5 1295
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MRubens and colleagues15 had included patients undergoing
aortic valve surgery and with different protocols of blood
product use established, such as re-administration of postop-
erative scavenged mediastinal blood. If cell-saving devices
are used, they can be disadvantageous because of the exces-
sive loss of coagulation factors and the delay of blood return.
A Canadian national survey reported that in 15 (41.7%) of
36 centers, cardiotomy suction was eliminated in some pa-
tients, particularly for CABG, and that 5 of those centers es-
tablished a volume cutoff for the conversion from the use of
a cell-saving device to the use of cardiotomy suction.28
Therefore, for the alternative use of cell-saving devices, an
optimal volume cutoff for the conversion needs to be deter-
mined in future studies, although the elimination of cardiot-
omy suction is currently impractical in some cardiac
surgeries such as redo valve procedures.
The present study had several limitations. First, for the
clinical outcomes, such as postoperative bleeding, transfu-
sions required, and graft patency, the sample size was too
small to allow comparisons among the groups or to rule
out a type II statistical error. For vein graft patency, a power
estimation analysis suggested that 97 patients per group
were needed to obtain an 80% power goal between 2
groups, considering an a error level of 5% and expecting
the incidence of vein graft patency to decrease from 96%
to 84%. Second, we did not quantify the volume of blood
retransfused through cardiotomy suction, because an addi-
tional cardiotomy reservoir and the temporary retainment
of the blood in the reservoir would have been necessary
for the quantification, and we were concerned that the addi-
tional canister and blood retainment might affect the hemo-
static results. Third, with regard to the inflammatory system,
our study evaluated only the representative inflammatory
markers of C3a and IL-6; thus, other inflammatory marker
levels were unknown. Fourth, our study did not evaluate
postoperative cognitive function. The association between
the use of cardiotomy suction and postoperative cognitive
dysfunction has been examined, although the results have
been controversial.2,15,16,27
CONCLUSIONS
The present study had the following 3 findings. First,
the use of cardiotomy suction, but not open venous reser-
voirs, caused perioperative activation of coagulation and fi-
brinolysis. Second, the current heparin protocol (celite ACT
more than 400 seconds) completely suppressed thrombin ac-
tivation when cardiotomy suction was eliminated. Third,
neither cardiotomy suction nor open venous reservoirs af-
fected inflammation marker levels and platelet depletion.
These findings could be helpful for determining optimal an-
ticoagulation during CPB, for appropriately use of an open
venous reservoir or cardiotomy suction, and to achieve
less-invasive and more biocompatible use of CPB to im-
prove the outcomes after cardiac surgery.1296 The Journal of Thoracic and Cardiovascular SurWe appreciate the assistance of the Departments of Anesthesiol-
ogy and Extracorporeal Circulation, the Central Clinical Labora-
tory (Osaka City University Hospital, Osaka, Japan), and the
Laboratory of Statistics (Osaka City University Graduate School
of Medicine, Osaka, Japan).
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